ELDON BIOLOGICALS A/S: Financial statements 2020
CVR: 26747007
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 14,331,404 and a net result of DKK 6,608,688 compared with DKK 3,309,735 the year before. That is an increase of 50.3% compared with the year before. Equity amounted to DKK 16,549,055. The solvency ratio was 75.3%. The company had 8 employees in the financial year.
- Gross Profit
- 14,331,404 kr.
- Profit/Loss
- 6,608,688 kr.
- Equity
- 16,549,055 kr.
- Total Assets
- 21,971,570 kr.
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 14.3 mio. | 6.6 mio. | 16.5 mio. | 8 |
| 2019 | - | 9.5 mio. | 3.3 mio. | 10.5 mio. | 6 |
| 2018 | - | 9.5 mio. | 3.8 mio. | 7.1 mio. | 7 |
| 2017 | - | 8 mio. | 2.6 mio. | 3.9 mio. | 7 |
| 2016 | - | 6.1 mio. | 1.2 mio. | 1.3 mio. | - |
How creditworthy is ELDON BIOLOGICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 1, 2020, Kasper Juul Hedegaard is registered as adm. dir. of ELDON BIOLOGICALS A/S.
As of December 1, 2020, Hans-Ole Hedegaard has stepped down as director of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.
